NEW YORK (GenomeWeb News) – Wake Forest University and spin-out company NanoMedica have received $860,000 in funding to move a bead-based genetic sequencing drug discovery technology closer to commercialization, Wake Forest said today.

The funding includes a $700,000 Small Business Innovation Research award from the National Institutes of Health and a $160,000 grant from the North Carolina Biotechnology Center.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.